Skip to contentT
Thermo Fisher Scientific Inc.
T
TMOThermo Fisher Scientific Inc. Q3 2023 · 10-Q
Revenue$10.57B$10.57B−1.0% vs Q3 2022 Net Income$1.70B$1.70B+13.2% vs Q3 2022 EPS Diluted$4.42$4.42+16.6% vs Q3 2022 Operating Income$1,864,000,000+9.0% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Thermo Fisher Scientific Inc. · CIK 97745 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$2,082,000,000+49.8% Margins · derivedOperating margin17.6%+1.6 pt vs Q3 2022
Net margin16.0%+2.0 pt vs Q3 2022
ended Sep 30, 2023 · filed Nov 3, 2023 · 34 d after period end